IHH Healthcare Q0F has more than doubled its earnings for the 3QFY2023 ended Sept 30 to RM532.1 million ($152 million)ompared to RM251.8 million for the same period last year, boosted by operational growth from higher patient volumes and revenue intensity from higher acuity treatment.
Accordingly, earnings per share also increased to 6.04 sen for the quarter compared to 2.78 sen in 3QFY2022
For the same period, IHH revenue increased by 27% to RM5.8 billion on higher revenue intensity across all markets as more patients were seen.
The company’s net operating income, which reflects its core performance, was up by 17% y-o-y to RM368.9 million in 3QFY2023.
On Aug 29, IHH declared an interim cash dividend of 3.5 sen per share that was paid on Oct 27.
The company says it is confident of its organic growth trajectory and will continue to manage costs efficiently by expanding bed capacity, driving inpatient volume growth, upgrading facilities and equipment to provide better patient care and cater to demand and enhance revenue intensity
Over the next five years, IHH is planning on increasing its bed capacity by some 33%, adding 4,000 new beds across Malaysia, India, Hong Kong, Turkey and Europe.
Overall, IHH expects continued revenue growth and double-digit return on equity (ROE), while maintaining prudent capital management and mitigating inflationary and interest rates pressures.
Shares in IHH closed 1 cent or 0.6% up on Nov 30.
